LexisNexis Risk Solutions Acquires Human API
LexisNexis Risk Solutions, a division of Reed Elsevier, announced on March 6 that it acquired Human API, a San Mateo, California-based company. Human API’s proprietary consumer consent management platform enables more seamless delivery of health data between consumers and life insurance and healthcare organizations. The financial terms of the acquisition were not disclosed. LexisNexis Risk Solutions is a global provider of content-enabled workflow solutions designed specifically for professionals in the legal, risk management, corporate, government, law enforcement, accounting and academic markets. It was founded in 1997 and is based in Atlanta. Human API enables insurance, life sciences... Read More »
Transcarent to Acquire On-Demand Primary Care Company 98point6
Transcarent announced its plans to acquire 98point6. According to data captured in the LevinPro HC database, this acquisition represents the 49th eHealth transaction of 2023, seven of them in the telehealth specialty. Founded in 2015, 98point6 is an AI-powered, digital primary care service that provides personalized consultation, diagnosis and treatment to patients. The transaction is expected to close March 31, 2023, after which 98point6 will continue to develop technology solutions and focus its efforts on licensing its 98point6 technology platform software to third-party health care providers. Transcarent’s acquisition of 98point6’s technology and the ability to closely partner with an... Read More »
agilon health Acquires mphrX in $45 Million Deal
agilon health has acquired mphrX with a $45 million investment. Management does not anticipate mphrX will have a meaningful impact on agilon’s adjusted EBITDA in 2023. Macquarie Capital Partners, LLC served as exclusive financial advisor to mphrX. mphrX created the Minerva Healthcare Data Platform, which uses FHIR-based standards to help organizations aggregate, access and store data across healthcare delivery networks. agilon health provides the technology, people, capital, process and access to a peer network of more than 2,200 primary care physicians that allow physician groups to maintain their independence. According to data captured in the LevinPro HC database, this transaction marks... Read More »
WeInfuse Secures Growth Investment from Curewell Capital
Curewell Capital has made a significant growth equity investment in WeInfuse to support the company’s continued expansion and strategic initiatives. WeInfuse will use the newly secured funds to invest in its foundational software platform for infusion centers and accelerate its home infusion and specialty pharmacy solutions. To continue delivery of software solutions to providers of specialty infusion services, Curewell and WeInfuse have formed the Infusion Technology Advisory Council (ITAC), assembling industry leaders from the infusion, specialty pharmacy and healthcare technology sectors. As part of the investment, Michael Dal Bello and Ceron Rhee, partners at Curewell Capital,... Read More »
LOGEX Announces Investment from Thoma Bravo
LOGEX announced on March 1 an investment from Thoma Bravo, a leading software investment firm. LOGEX’s existing shareholders, the company’s founders and Summa Equity will remain invested with the business and will work closely with Thoma Bravo and the executive committee to support LOGEX’s European growth and further drive innovation in healthcare analytics. This marks Thoma Bravo’s inaugural investment by its European team. Jefferies LLC served as the exclusive financial advisor to LOGEX and Allen & Overy served as legal counsel. Kirkland & Ellis LLP served as legal counsel to Thoma Bravo and Harris Williams LLC served as Thoma Bravo’s exclusive... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
